single-molecule sequencing
Pacific Biosciences Reports 3 Percent Decrease in Q4 Revenues
Q4 revenues totaled $27.1 million, down from $27.9 million in Q4 of 2019 but beating the average Wall Street estimate of $25.4 million.
Pacific Biosciences to Obtain $900M Investment From SoftBank Subsidiary
The company plans to use the new funding, which will come from the sale of convertible senior notes due 2028, to support unspecified future growth initiatives.
Startup Angstrom Bio Plans Saliva-Based COVID-19 Nucleic Acid Test on Nanopore Sequencing Platform
Premium
Angstrom Bio is developing a rapid, scalable coronavirus test that uses nanopore sequencing to detect barcoded PCR products.
Invitae, Pacific Biosciences Collaborate on NGS-Based Pediatric Epilepsy Testing
The firms will conduct PacBio whole-genome sequencing on epilepsy patients to generate variant profiles that can help the development of diagnostic assays.
Pacific Biosciences, Children's Mercy, Microsoft Collaborate on Rare Genetic Disease Diagnostics
The organizations will apply PacBio's HiFi sequencing to a rare disease cohort whose genomes have not yet yielded causal variants by other methods.
Oct 8, 2020
Aug 3, 2020
Pacific Biosciences Q2 Revenues Drop 14 Percent
May 6, 2020
Pacific Biosciences Q1 Revenues Down 5 Percent
Feb 11, 2020
Feb 6, 2020
Pacific Biosciences Q4 Revenues Jump 43 Percent
May 3, 2019
Pacific Biosciences Q1 Revenues Fall 15 Percent
Mar 7, 2019